Effects of sphingosine-1-phosphate and sphingosylphosphorylcholine on intracellular Ca2+ and cell death in prostate cancer cell lines

Autonomic and Autacoid Pharmacology

Volumn 27, Issue 4, 2007, Pages 173-179

  Mulders, A C M ^a   Nau, S ^b   Li, Y ^b   Michel, M C ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Apoptosis; DU 145; Intracellular Ca2+; PC3; Sphingosine 1 phosphate; Sphingosylphosphorylcholine

Indexed keywords

SPHINGOSINE 1 PHOSPHATE; SPHINGOSYLPHOSPHORYLCHOLINE;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CELL COUNT; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; PROSTATE CANCER;

APOPTOSIS; CALCIUM; CELL DEATH; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTRACELLULAR FLUID; LYSOPHOSPHOLIPIDS; MALE; PHOSPHORYLCHOLINE; PROSTATIC NEOPLASMS; SPHINGOSINE;

EID: 36849066265     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.2007.00410.x     Document Type: Article

References (23)

1. AKAO, Y., BANNO, Y., NAKAGAWA, Y., HASEGAWA, N., KIM, T.-J., MURATE, T., IGARASHI, Y. NOZAWA, Y. (2006). High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation. Biochem. Biophys. Res. Commun., 342, 1284 1290.
2. ALEWIJNSE, A.E. MICHEL, M.C. (2006). Sphingosine-1-phosphate and sphingosylphosphorylcholine: two of a kind? Br. J. Pharmacol., 147, 347 348.
3. BERRIDGE, M.J., BOOTMAN, M.D. LIPP, P. (1998). Calcium - a life and death signal. Nature, 395, 645 648.
4. CHALFANT, C.E. SPIEGEL, S. (2005). Sphingosine-1-phosphate and ceramide-1-phosphate: expanding roles in cell signaling. J. Cell Sci., 118, 4605 4612.
5. CHUN, J., GOETZL, E.J., HLA, T., IGARASHI, Y., LYNCH, K.R., MOOLENAAR, W., PYNE, S. TIGYI, G. (2002). International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol. Rev., 54, 265 269.
6. GIBBS, T.C., XIE, Y. MEIER, K.E. (2000). Regulation of expression of EDG family receptors in human prostate cancer cell lines. Ann. N. Y. Acad. Sci., 905, 290 293.
7. HARRIS, K.A. REESE, D.M. (2001). Treatment options in hormone-refractory prostate cancer: current and future approaches. Drugs, 61, 2177 2192.
8. HINOI, E., FUJIMORI, S., TAKEMORI, A. YONEDA, Y. (2002). Cell death by pyruvate deficiency in proliferative cultured calvarial osteoblasts. Biochem. Biophys. Res. Commun., 294, 1177 1183.
9. HSING, A.W. CHOKKALINGAM, A.P. (2006). Prostate cancer epidemiology. Front Biosci., 11, 1388 1413.
10. 3. Br. J. Pharmacol., 149, 277 282.
11. KINLOCH, R.A., TREHERNE, J.M., FURNESS, L.M. HAJIMOHAMADREZA, I. (1999). The pharmacology of apoptosis. Trends Pharmacol. Sci., 20, 35 42.
12. KOLESNICK, R. HANNUN, Y.A. (1999). Ceramide and apoptosis. Trends Biochem. Sci., 24, 224 225.
13. LIAO, J.J., HUANG, Y.T. LEE, H. (2005). Inhibitory effects of sphingosine-1-phosphate on proliferation of PC-3 human prostate cancer cells. Zool. Stud., 44, 219 227.
14. MEYER ZU HERINGDORF, D., VAN KOPPEN, C.J. JAKOBS, K.H. (1997). Molecular diversity of sphingolipid signalling. FEBS Lett., 410, 34 38.
15. MEYER ZU HERINGDORF, D., HIMMEL, H.M. JAKOBS, K.H. (2002). Sphingosylphosphorylcholine-biological functions and mechanisms of action. Biochim. Biophys. Acta, 1582, 178 189.
16. NAETZKER, S., HAGEN, N. ECHTEN-DECKERT, G. (2006). Activation of p38 mitogen-activated protein kinase and partial reactivation of the cell cycle by cis-4-methylsphingosine direct postmitotic neurons towards apoptosis. Genes Cells, 11, 269 279.
17. PCHEJETSKI, D., GOLZIO, M., BONHOURE, E. et al. (2005). Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res., 65, 1167 1175.
18. SHIRAHAMA, T., SAKAKURA, C., SWEENEY, E.A., OZAWA, M., TAKEMOTO, M., NISHIYAMA, K., OHI, Y. IGARASHI, Y. (1997). Sphingosine induces apoptosis in androgen-independent human prostatic carcinoma DU 145 cells by suppression of bcl-X(L) gene expression. FEBS Lett., 407, 97 100.
19. SOBEL, R.E. SADAR, M.D. (2005a). Cell lines used in prostate cancer research: a compendium of old and new lines - part 1. J. Urol., 173, 342 359.
20. SOBEL, R.E. SADAR, M.D. (2005b). Cell lines used in prostate cancer research: a compendium of old and new lines - part 2. J. Urol., 173, 360 372.
21. SPIEGEL, S. MILSTIEN, S. (2003). Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol., 4, 397 407.
22. 1-adrenoceptor subtype coupling to protein kinase C activation and related signalling pathways. Naunyn-Schmiedeberg's Arch. Pharmacol., 358, 100 110.
23. XIE, Y., GIBBS, T.C., MUKHIN, Y.V. MEIER, K.E. (2002). Role for 18:1 lysophosphatidic acid as an autocrine mediator in prostate cancer cells. J. Biol. Chem., 277, 32516 32526.